Evaluating progression-free survival in black and white women with triple-negative breast cancer in pooled clinical trials from a synthetic control database (SCD) and real-world electronic medical records (EMR).

Mark Layton Watson, Kevin Holcomb, Lisa Newman, Janna Andrews, Lisa Ensign, Aaron Galaznik, Bryant Fields, Sheila Diamond, Nicole Pollard